GnT Antibodies

Santa Cruz Biotechnology features a diverse variety of GnT Antibodies for targeting glycosyltransferases involved in the glycosylation process. Monoclonal GnT Antibodies serve as essential research tools in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycosyltransferases play a crucial role in the modification of proteins and lipids through the addition of carbohydrate moieties, which are essential for proper cellular function, signaling, and recognition. The study of glycosylation patterns is vital for understanding various biological processes and disease mechanisms, including cancer progression and immune responses. GnT Antibodies enable researchers to explore and analyze specific glycosylation events in cellular pathways. Investigating glycosylation modifications provides valuable information about protein trafficking, cell-cell interactions, and developmental processes. Understanding the role of glycosyltransferases can lead to new therapeutic strategies for various diseases. The extensive selection of monoclonal GnT Antibodies from Santa Cruz Biotechnology supports researchers worldwide in advancing scientific knowledge about glycosylation's role in health and disease.